# Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies

> **NCT02323867** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Children's Hospital of Philadelphia** · enrollment: 140 (estimated)

## Conditions studied

- Leukemia
- Lymphoma
- Myelodysplasia

## Interventions

- **DEVICE:** Alpha Beta T cell depletion

## Key facts

- **NCT ID:** NCT02323867
- **Lead sponsor:** Children's Hospital of Philadelphia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2014-10
- **Primary completion:** 2026-10
- **Final completion:** 2027-10
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2025-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02323867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02323867, "Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT02323867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*